Source: Eur Respir J 2014; 43: 898-900
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hilmarsen Christina W., Wilke Sarah, Engan Harald, Spruit Martijn A., Rodenburg Johan, Janssen Daisy J.A., Steinshamn Sigurd, Jones Paul W., Wouters Emiel F.M., Oldervoll Line, Franssen Frits M.E.. Impact of symptoms of anxiety and depression on COPD Assessment Test scores. Eur Respir J 2014; 43: 898-900

Member's Comments

No comment yet.

Related content which might interest you: Symptoms of anxiety and depression and CAT scores in COPD patients entering pulmonary rehabilitation Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Symptoms of anxiety and depression Source: School Course 2014 - Pulmonary Rehabilitation Year: 2014 Depression in chronic obstructive pulmonary disease: Predictors and accuracy of the hospital anxiety and depression scale (HADS) Source: International Congress 2014 – Latest insights in chronic care Year: 2014 Impact of anxiety and depression in asthma control Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Psychological comorbidity (depression and anxiety) in children with asthma Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 Assessment of quality of life, anxiety and depression in patients with chronic cough Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Depression and anxiety in patients with COPD Source: Eur Respir Rev 2014; 23: 345-349 Year: 2014 Effect of gender on exercise capacity and hospital anxiety and depression scale (HADS) score following pulmonary rehabilitation Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011 Beck depression inventory-II: Determination and comparison of its diagnostic accuracy in asthmatic outpatients Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Does adding the Generalised Anxiety Disorder (GAD) questionnaire and Patient Health Questionnaire-9 (PHQ-9) to routine outpatient activity provide more information on the presence of anxiety and depression in asthma? Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018 Health-related quality of life in COPD: why both disease-specific and generic measures should be used Source: Eur Respir J 2001; 18: 69-76 Year: 2001 Anxiety and depression in patients with asthma Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011 Anxiety and depression in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 275s Year: 2005 Anxiety and depression in patients with asthma Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Depressive symptomatology in COPD patients Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Impact of pulmonary rehabilitation on anxiety and depression in patients with COPD Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Assessment of anxiety-depression disorders in patients with bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD Source: Eur Respir J 2010; 36: 96-104 Year: 2010 Fatigue, coping, anxiety and depression in patients with sarcoidosis Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021